Structure Therapeutics GPCR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 28.00 | 112.47 | -0.37 | -73,787 | -66 | |
| 2025Q2 | 20.74 | 114.51 | -0.36 | -70,451 | -62 | |
| 2025Q1 | 17.31 | 120.49 | -0.27 | -56,311 | -47 | |
| 2024Q4 | 27.12 | 129.49 | -0.22 | -47,061 | -36 | |
| 2024Q3 | 43.89 | 135.27 | -0.20 | -45,836 | -34 | |
| 2024Q2 | 39.27 | 128.23 | -0.17 | -33,316 | -26 | |
| 2024Q1 | 42.86 | -0.19 | -32,015 | -26 | ||
| 2023Q4 | 40.76 | -0.16 | -30,994 | -25 | ||
| 2023Q3 | 50.42 | -0.21 | -26,145 | -24 | ||
| 2023Q2 | 41.57 | -0.19 | -25,987 | -23 | ||
| 2023Q1 | 23.79 | -0.25 | -19,649 | -18 | ||
| 2022Q4 | -1.17 | -12,956 | -12 | |||
| 2022Q3 | -0.49 | -12,693 | -14 | |||
| 2022Q2 | -0.61 | -13,960 | -14 | |||
| 2022Q1 | -0.51 | -12,952 | -13 | |||
| 2021Q4 | -13 | 0 | ||||
| 2020Q4 | -15,906 | -16 |